1276 — Jiangsu Hengrui Pharmaceuticals Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$356.27bn
- HK$330.54bn
- CNY27.98bn
Annual cashflow statement for Jiangsu Hengrui Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -16,554 | -18,171 | -14,598 | -13,706 | -16,032 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 3,432 | 4,219 | 1,265 | 7,644 | 7,423 |
| Capital Expenditures | -554 | -1,665 | -1,992 | -1,484 | -1,969 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2,352 | 1,118 | 2,382 | 2,706 | 57.2 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,798 | -546 | 390 | 1,222 | -1,912 |
| Financing Cash Flow Items | 1,308 | 67.9 | -563 | -862 | -276 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 291 | -998 | -319 | -3,144 | -1,551 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5,432 | 2,657 | 1,417 | 5,734 | 3,968 |